Immune checkpoint inhibitor–Induced colitis Journal Article


Authors: Thomas, A. S.; Lu, Y.; Campbell, M.; Thompson, J. A.; Tan, D.; Faleck, D. M.; Wang, Y.
Article Title: Immune checkpoint inhibitor–Induced colitis
Keywords: adult; clinical article; human tissue; treatment response; metaplasia; prednisone; histopathology; case report; diarrhea; drug dose reduction; drug withdrawal; note; cancer staging; biological marker; cancer immunotherapy; edema; computer assisted tomography; multiple cycle treatment; breast cancer; anemia; image analysis; inflammation; creatinine; hemoglobin; vascularization; renal cell carcinoma; abdominal pain; arthralgia; gastrointestinal toxicity; symptom; b cell lymphoma; cancer regression; body mass; disease severity; partial nephrectomy; active surveillance; contrast enhancement; colonoscopy; family history; erythema; remission; recurrent disease; colitis; immune deficiency; drug substitution; uterus cancer; endoscopy; abdominal cramp; mother; ablation therapy; drug induced disease; abdominal wall; colon biopsy; antidiarrheal agent; medical history; abscess; mucus secretion; paneth cell; bloody diarrhea; lactoferrin; colon ulcer; sigmoid; experimental therapy; metrorrhagia; nose disease; colon hemorrhage; immune checkpoint inhibitor; abdominal tenderness; tofacitinib; transverse colon; drug rechallenge; human; female; fecal microbiota transplantation; pembrolizumab; plasmacytosis; loss of appetite; descending colon; immune checkpoint inhibitors; vedolizumab; calgranulin; ex-smoker; ustekinumab; paternal aunt; fecal transplant; colon crypt; cryptitis; grandmother; pancolitis; sinus discomfort
Journal Title: Gastroenterology
Volume: 168
Issue: 1
ISSN: 0016-5085
Publisher: Elsevier Inc.  
Date Published: 2025-01-01
Start Page: 21
End Page: 28
Language: English
DOI: 10.1053/j.gastro.2024.09.034
PUBMED: 39389184
PROVIDER: scopus
DOI/URL:
Notes: Note -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David M. Faleck
    51 Faleck